Skip Nav Destination
Issues
15 June 2004
ISSN 1078-0432
EISSN 1557-3265
Issue Sections
Editorial
Reviews
Report from the FDA
Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma
Peter F. Bross; Robert Kane; Ann T. Farrell; Sophia Abraham; Kimberly Benson; Margaret E. Brower; Sean Bradley; Jogarao V. Gobburu; Anwar Goheer; Shwu-Luan Lee; John Leighton; Cheng Yi Liang; Richard T. Lostritto; William D. McGuinn; David E. Morse; Atiqur Rahman; Lilliam A. Rosario; S. Leigh Verbois; Grant Williams; Yong-Cheng Wang; Richard Pazdur
Featured Articles
Clinical Trials
A Novel Effective and Safe Consolidation for Patients Over 60 Years with Acute Myeloid Leukemia: Intermediate Dose Cytarabine (2 × 1 g/m2 on Days 1, 3, and 5)
Wolfgang R. Sperr; Maria Piribauer; Friedrich Wimazal; Christa Fonatsch; Renate Thalhammer-Scherrer; Ilse Schwarzinger; Klaus Geissler; Paul Knöbl; Ulrich Jäger; Klaus Lechner; Peter Valent
Molecular Oncology, Markers, Clinical Correlates
Tetranucleotide Microsatellite Instability in Surgical Margins for Prediction of Local Recurrence of Head and Neck Squamous Cell Carcinoma
Stephane Temam; Odile Casiraghi; Jean-Baptiste Lahaye; Jacques Bosq; Xian Zhou; Morbize Julieron; Gerard Mamelle; J. Jack Lee; Li Mao; Bernard Luboinski; Jean Benard; Francois Janot
Experimental Therapeutics, Preclinical Pharmacology
Anti-Invasive, Antitumoral, and Antiangiogenic Efficacy of a Pyrimidine-2,4,6-trione Derivative, an Orally Active and Selective Matrix Metalloproteinases Inhibitor
Erik Maquoi; Nor Eddine Sounni; Laetitia Devy; Fabrice Olivier; Francis Frankenne; Hans-Willi Krell; Frank Grams; Jean-Michel Foidart; Agnès Noël
Regular Articles
Clinical Trials
Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium Infusions: A Retrospective Study of 161 Patients Receiving Oxaliplatin Combined with 5-Fluorouracil and Leucovorin for Advanced Colorectal Cancer
Laurence Gamelin; Michele Boisdron-Celle; Remy Delva; Véronique Guérin-Meyer; Norbert Ifrah; Alain Morel; Erick Gamelin
Phase II Study of Celecoxib and Trastuzumab in Metastatic Breast Cancer Patients Who Have Progressed after Prior Trastuzumab-Based Treatments
Chau T. Dang; Andrew J. Dannenberg; Kotha Subbaramaiah; Maura N. Dickler; Mark M. Moasser; Andrew D. Seidman; Gabriella M. D’Andrea; Maria Theodoulou; Katherine S. Panageas; Larry Norton; Clifford A. Hudis
The Effect of Food on the Pharmacokinetics of S-1 after Single Oral Administration to Patients with Solid Tumors
Godefridus J. Peters; Paul Noordhuis; Cornelis J. van Groeningen; Giuseppe Giaccone; Ulbe Holwerda; Daphne Voorn; Ad Schrijvers; Jan H. Schornagel; Jos H. Beijnen; Pierre Fumoleau; Jan H. M. Schellens
Research Articles
Molecular Oncology, Markers, Clinical Correlates
HER-2 Gene Amplification Correlates with Higher Levels of Angiogenesis and Lower Levels of Hypoxia in Primary Breast Tumors
Kimberly L. Blackwell; Mark W. Dewhirst; Vlayka Liotcheva; Stacey Snyder; Gloria Broadwater; Rex Bentley; Anita Lal; Gregory Riggins; Steve Anderson; Jim Vredenburgh; Alan Proia; Lyndsay N. Harris
Protein Kinase C θ Is Highly Expressed in Gastrointestinal Stromal Tumors But Not in Other Mesenchymal Neoplasias
Pilar Blay; Aurora Astudillo; José M. Buesa; Elías Campo; Mar Abad; Juan García-García; Rosa Miquel; Vicente Marco; Marta Sierra; Raquel Losa; Angel Lacave; Alejandro Braña; Milagros Balbín; José M. P. Freije
Association between Expression of Transcription Factor Sp1 and Increased Vascular Endothelial Growth Factor Expression, Advanced Stage, and Poor Survival in Patients with Resected Gastric Cancer
James C. Yao; Liwei Wang; Daoyan Wei; Weida Gong; Manal Hassan; Tsung-Teh Wu; Paul Mansfield; Jaffer Ajani; Keping Xie
Ki-67 Staining Index Predicts Distant Metastasis and Survival in Locally Advanced Prostate Cancer Treated With Radiotherapy: An Analysis of Patients in Radiation Therapy Oncology Group Protocol 86-10
Rile Li; Kateri Heydon; M. Elizabeth Hammond; David J. Grignon; Mack Roach, III; Harvey B. Wolkov; Howard M. Sandler; William U. Shipley; Alan Pollack
N-Cadherin Expression and Epithelial-Mesenchymal Transition in Pancreatic Carcinoma
Sanae Nakajima; Ryuichiro Doi; Eiji Toyoda; Shoichiro Tsuji; Michihiko Wada; Masayuki Koizumi; Sidhartha S. Tulachan; Daisuke Ito; Kazuhiro Kami; Tomohiko Mori; Yoshiya Kawaguchi; Koji Fujimoto; Ryo Hosotani; Masayuki Imamura
Experimental Therapeutics, Preclinical Pharmacology
CpG Immunostimulatory Oligodeoxynucleotide 1826 Enhances Antitumor Effect of Interleukin 12 Gene-Modified Tumor Vaccine in a Melanoma Model in Mice
Tomasz Switaj; Ahmad Jalili; Anna B. Jakubowska; Nadzieja Drela; Magdalena Stoksik; Dominika Nowis; Grzegorz Basak; Jakub Golab; Piotr J. Wysocki; Andrzej Mackiewicz; Agata Sasor; Koryna Socha; Marek Jakóbisiak; Witold Lasek
Mcl-1 Is a Novel Therapeutic Target for Human Sarcoma: Synergistic Inhibition of Human Sarcoma Xenotransplants by a Combination of Mcl-1 Antisense Oligonucleotides with Low-Dose Cyclophosphamide
Christiane Thallinger; Markus F. Wolschek; Helmut Maierhofer; Hans Skvara; Hubert Pehamberger; Brett P. Monia; Burkhard Jansen; Volker Wacheck; Edgar Selzer
Corrections
Supplement Articles
Proceedings of the First International Conference
Novel Agents in the Treatment of Lung Cancer: Conference Summary Statement
Thomas J. Lynch; Alex A. Adjei; Paul A. Bunn, Jr.; Raymond N. DuBois; David R. Gandara; Giuseppe Giaccone; Ramaswamy Govindan; Roy S. Herbst; Bruce E. Johnson; Fadlo R. Khuri; Roman Perez-Soler; Rafael Rosell; Eric K. Rowinsky; Alan B. Sandler; Giorgio V. Scagliotti; Joan H. Schiller; Geoffrey I. Shapiro; Mark A. Socinski; Carol S. Hart
Gene Expression as a Predictive Marker of Outcome in Stage IIB-IIIA-IIIB Non-Small Cell Lung Cancer After Induction Gemcitabine-Based Chemotherapy Followed By Resectional Surgery
Rafael Rosell; Enriqueta Felip; Miquel Taron; Joaquim Majo; Pedro Mendez; Maria Sanchez-Ronco; Cristina Queralt; Jose Javier Sanchez; Jose Maestre
Advertisement
